IL-7 R alpha

IL-7 R alpha 詳細

英語名Interleukin-7 receptor subunit alpha市販薬剤の数0
治験薬の数8ターゲットの別称Interleukin-7 receptor subunit alpha,Interleukin 7 Receptor Isoform H5-6,CDw127,IL-7R subunit alpha,IL-7RA,IL-7 receptor subunit alpha,CD127 Antigen,IL-7R-Alpha,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subunit
研究&開発段階Phase 2 Clinical
英語名Interleukin-7 receptor subunit alpha
ターゲットの別称Interleukin-7 receptor subunit alpha,Interleukin 7 Receptor Isoform H5-6,CDw127,IL-7R subunit alpha,IL-7RA,IL-7 receptor subunit alpha,CD127 Antigen,IL-7R-Alpha,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subunit
市販薬剤の数0
治験薬の数8
研究&開発段階Phase 2 Clinical

IL-7 R alpha 製品リスト

  • 属性

    Protein (7)

  • 製品ライブラリ

    オンライン (7)

  • Human (5)Mouse (1)Cynomolgus (1)

  • タグ

    Mouse IgG Fc Tag (2)Fc Tag (2)Fc Tag & Avi Tag (1)His Tag (2)

  • マーカー

    Unconjugated (6)Biotin-labeled (1)

IL-7 R alphaバックグランド

Interleukin-7 receptor subunit alpha (IL7Ra) is also known as CD antigen CD127, which belongs to the type I cytokine receptor family and type 4 subfamily. IL7Ra /CD127 contains 1 fibronectin type-III domain. IL7Ra /CD127 is expressed on various cell types, including naive and memory T cells and many others. IL7Ra /CD127 is receptor for interleukin-7 and also acts as a receptor for thymic stromal lymphopoietin (TSLP). The IL7 receptor is a heterodimer of IL7R and IL2RG. The TSLP receptor is a heterodimer of CRLF2 and IL7R.

IL-7 R alpha分子の別称

IL7Ra,CD127

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CYT-107CYT-107; CYT-99-007; rhIL-7Phase 2 ClinicalRevimmune IncCarcinoma, Renal Cell; Carcinoma, Transitional Cell; Catheter-Related Infections; Coronavirus Disease 2019 (COVID-19); Hepatitis B, Chronic; Hepatitis C; HIV Infections; Kidney Neoplasms; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphopenia; Metastatic breast cancer; Multiple Myeloma; Mycobacterium Infections, Nontuberculous; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neuroblastoma; Neuroectodermal Tumors, Primitive, Peripheral; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sarcoma; Sarcoma, Kaposi; Sepsis; Shock, Septic; Skin Melanoma; T-Lymphocytopenia, Idiopathic CD4-Positive; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms
詳細
LusvertikimabOSE-127; S-95011; Effi-7; OSE-217Phase 2 ClinicalEffimuneColitis, Ulcerative; Sjogren's Syndrome
詳細
Efineptakin alfaTJ-107; GX-I7; NT-I7Phase 2 ClinicalGannex Pharma Co LtdAstrocytoma; Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Esophageal Neoplasms; Glioblastoma; Glioma; Gliosarcoma; HIV Infections; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Leukoencephalopathy, Progressive Multifocal; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphopenia; Melanoma; Multiple Myeloma; Oropharyngeal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Plasmablastic Lymphoma; Prostatic Neoplasms, Castration-Resistant; Sarcoma, Kaposi; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
詳細
ASP-9801ASP-9801Phase 1 ClinicalAstellas Pharma IncNeoplasm Metastasis; Neoplasms; Solid tumours
詳細
PF-06342674RN-168; PF-6342674; PF-06342674; ZB-168Phase 1 ClinicalPfizer IncDiabetes Mellitus, Type 1; Multiple Sclerosis
詳細
CD19-IL7Ra CAR-T cells therapy (Chulalongkorn University)CMD-63; CMD63Phase 1 ClinicalChulalongkorn UniversityPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma
詳細
Loco-regional B7H3 IL-7Ra CAR T Cell therapy(Chulalongkorn University)Phase 1 ClinicalChulalongkorn University, King Chulalongkorn Memorial HospitalBrain Neoplasms; Diffuse Intrinsic Pontine Glioma; Neoplasms; Solid tumours
詳細
MDK-703MDK-703Phase 1 ClinicalMedikine IncSolid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8